Skip to main content
Top
Published in: Rheumatology International 12/2019

01-12-2019 | Systemic Lupus Erythematosus | Observational Research

Renal flare in class V lupus nephritis: increased risk in patients with tubulointerstitial lesions

Authors: Oh Chan Kwon, Yong Mee Cho, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim

Published in: Rheumatology International | Issue 12/2019

Login to get access

Abstract

The objective of this study is to investigate the risk factors of renal flare in patients with membranous lupus nephritis (class V lupus nephritis). Biopsy-proven pure membranous lupus nephritis patients diagnosed between January 1997 and September 2017 were studied. We assessed and compared the clinical and pathological parameters between patients who experienced renal flare and those who did not. To identify risk factors of renal flare, multivariable Cox proportional hazard regression analysis was performed. Out of the 53 patients with pure membranous lupus nephritis, 17 patients (32.1%) experienced renal flare during a median follow-up of 121.5 months (range 44.4–196.9). Patients who experienced renal flare had significantly higher proportion of tubulointerstitial inflammation (76.5% vs. 36.1%, p = 0.006) and tubular atrophy/interstitial fibrosis (70.6% vs. 27.8%, p = 0.003) at baseline. In multivariable Cox proportional hazard regression analysis, the presence of tubulointerstitial inflammation [adjusted hazard ratio (HR) 5.532, 95% confidence interval (CI) 1.722–17.776, p = 0.004] and tubular atrophy/interstitial fibrosis (adjusted HR 4.328, 95% CI 1.450–12.916, p = 0.009) at baseline was significantly associated with increased risk of renal flare. The presence of tubulointerstitial inflammation and tubular atrophy/interstitial fibrosis is associated with increased risk of renal flare in patients with membranous lupus nephritis.
Literature
1.
go back to reference Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRef Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD et al (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557CrossRef
2.
go back to reference Na W, Yi K, Song YS, Park MH (2017) Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy. PLoS One 12:e0174501CrossRef Na W, Yi K, Song YS, Park MH (2017) Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy. PLoS One 12:e0174501CrossRef
3.
go back to reference Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRef Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRef
4.
go back to reference Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825–835CrossRef Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825–835CrossRef
5.
go back to reference Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13:483–495CrossRef Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13:483–495CrossRef
6.
go back to reference Chavarot N, Verhelst D, Pardon A, Caudwell V, Mercadal L, Sacchi A et al (2017) Rituximab alone as induction therapy for membranous lupus nephritis: a multicenter retrospective study. Medicine 96:e7429CrossRef Chavarot N, Verhelst D, Pardon A, Caudwell V, Mercadal L, Sacchi A et al (2017) Rituximab alone as induction therapy for membranous lupus nephritis: a multicenter retrospective study. Medicine 96:e7429CrossRef
7.
go back to reference Silva-Fernandez L, Oton T, Askanase A, Carreira P, Lopez-Longo FJ, Olive A et al (2019) Pure membranous lupus nephritis: description of a cohort of 150 patients and review of the literature. Reumatol Clin 15:34–42CrossRef Silva-Fernandez L, Oton T, Askanase A, Carreira P, Lopez-Longo FJ, Olive A et al (2019) Pure membranous lupus nephritis: description of a cohort of 150 patients and review of the literature. Reumatol Clin 15:34–42CrossRef
8.
go back to reference Ward F, Bargman JM (2016) Membranous lupus nephritis: the same, but different. Am J Kidney Dis 68:954–966CrossRef Ward F, Bargman JM (2016) Membranous lupus nephritis: the same, but different. Am J Kidney Dis 68:954–966CrossRef
9.
go back to reference Moroni G, Quaglini S, Gravellone L, Gallelli B, Leoni A, Messa P et al (2012) Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients. Semin Arthritis Rheum 41:642–651CrossRef Moroni G, Quaglini S, Gravellone L, Gallelli B, Leoni A, Messa P et al (2012) Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients. Semin Arthritis Rheum 41:642–651CrossRef
10.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRef
11.
go back to reference Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291PubMed Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291PubMed
12.
go back to reference Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRef Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRef
13.
go back to reference Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782CrossRef Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782CrossRef
14.
go back to reference Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH et al (2002) Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 46:995–1002CrossRef Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH et al (2002) Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 46:995–1002CrossRef
15.
go back to reference Ciruelo E, de la Cruz J, Lopez I, Gomez-Reino JJ (1996) Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 39:2028–2034CrossRef Ciruelo E, de la Cruz J, Lopez I, Gomez-Reino JJ (1996) Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 39:2028–2034CrossRef
16.
go back to reference Mejia-Vilet JM, Cordova-Sanchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R (2016) Renal flare prediction and prognosis in lupus nephritis Hispanic patients. Lupus 25:315–324CrossRef Mejia-Vilet JM, Cordova-Sanchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R (2016) Renal flare prediction and prognosis in lupus nephritis Hispanic patients. Lupus 25:315–324CrossRef
17.
go back to reference Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR (2011) Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) 63:865–874CrossRef Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR (2011) Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) 63:865–874CrossRef
18.
go back to reference Alsuwaida AO (2013) Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus 22:1446–1454CrossRef Alsuwaida AO (2013) Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus 22:1446–1454CrossRef
19.
go back to reference Daleboudt GM, Bajema IM, Goemaere NN, van Laar JM, Bruijn JA, Berger SP (2009) The clinical relevance of a repeat biopsy in lupus nephritis flares. Nephrol Dial Transplant 24:3712–3717CrossRef Daleboudt GM, Bajema IM, Goemaere NN, van Laar JM, Bruijn JA, Berger SP (2009) The clinical relevance of a repeat biopsy in lupus nephritis flares. Nephrol Dial Transplant 24:3712–3717CrossRef
20.
go back to reference Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P et al (2001) Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 37:490–498CrossRef Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P et al (2001) Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 37:490–498CrossRef
Metadata
Title
Renal flare in class V lupus nephritis: increased risk in patients with tubulointerstitial lesions
Authors
Oh Chan Kwon
Yong Mee Cho
Ji Seon Oh
Seokchan Hong
Chang-Keun Lee
Bin Yoo
Yong-Gil Kim
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04369-7

Other articles of this Issue 12/2019

Rheumatology International 12/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.